Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 3 (2018) ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina
"... to premature CVDs mortality in economic activity age with consideration on ratio of employment have included ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..."
 
Vol 7, No 3 (2011) COSTS OF THE HEALTH CARE IN RUSSIA ASSOCIATED WITH SMOKING Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina
"... : затраты, курение, система здравоохранения, экономический ущерб. РФК 2011;7(3):306-312 Costs of the health ..."
 
Vol 7, No 2 (2011) SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, I. E. Koltunov, R. G. Oganov
"... Aim. To estimate the economic damage by acute coronary syndrome (ACS) in Russia in 2006-2009 ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical prevention ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... with venous thromboembolism (VTE). Material and methods. Economic evaluation was performed from a position ..."
 
Vol 4, No 4 (2008) ECONOMIC REASONS FOR GENERIC CHOICE Abstract  similar documents
N. P. Kutishenko, S. Y. Martsevich, S. N. Tolpygina, J. V. Lukina
"... Выбор дженерика с точки зрения экономической целесообразности Н.П. Кутишенко*, С.Ю. Марцевич, С ..."
 
Vol 9, No 1 (2013) PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review Abstract  similar documents
T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev
"... учетом только прямых затрат, а также определением экономической эффективности препаратов в клинических ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... Aim. To estimate economic efficiency of a complex of resource-saving activities for cardiovascular ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... продолжительность жизни, общие затраты и показатели клинико-экономической эффективности в расчете на 100 пациенто ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... Aim. To evaluate by modelling the economic benefits of left ventricular hypertrophy (LVH ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Цель. Сравнить экономическую эффективность антигипертензивной терапии, основанной на дженерическом ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... Aim. To evaluate the economic effectiveness of the combined two-drug antihypertensive therapy ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... фозиноприла у больных артериальной гипертонией (АГ) 1-2 степени и оценка экономической эффективности замены ..."
 
Vol 6, No 6 (2010) EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) Abstract  similar documents
T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov
"... пациентов с рецидивирующей фибрилляцией предсердий (ФП) в амбулаторных условиях, оценить экономическую ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... .  Material and methods. Methods of cost-effectiveness analysis and economic modeling were used to calculate ..."
 
Vol 10, No 4 (2014) RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA Abstract  similar documents
T. Vekov
"... of pharmacotherapies in order to improve their economic efficiency and support the process of taking decisions ..."
 
Vol 15, No 1 (2019) The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years Abstract  similar documents
S. A. Shalnova, O. M. Drapkina
"... for Demographic Studies of the Russian Economic School, Moscow (Russia) were used. Mortality from CVD, including ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... . The incidence of cardiovascular diseases (CVDs) was determined according to the data from the medical ..."
 
Vol 14, No 2 (2018) TREATMENT OF INTERNAL CAROTID ARTERY OCCLUSION USING PROXIMAL CEREBRAL PROTECTION DEVICE AND ITS EFFECT ON THE BLOOD PRESSURE DYNAMICS. CLINICAL CASE Abstract  similar documents
F. В. Shukurov, D. S. Chigidinova, E. S. Bulgakova, B. A. Rudenko, T. V. Tvorogova, A. S. Shanoyan, O. M. Drapkina
"... huge economic damage to the country. One of the most common causes of ischemic stroke ..."
 
Vol 4, No 5 (2008) CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
M. V. Soura
"... Представлен обзор клинических и клинико-экономических исследований, а также результаты ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... diseases (CVD) in several regions of the Russian Federation with different climatic, geographic, economic ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... Цель. Сравнить экономическую эффективность применения прямых ингибиторов Ха фактора ривароксабана ..."
 
Vol 12, No 4 (2016) Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk Abstract  PDF (Eng)  similar documents
F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva
"... population, in men and in women and in majority of age subgroups. This can be explained by economic, social ..."
 
Vol 4, No 4 (2008) COMPARISON OF DIFFERENT STRATEGIES OF ANTIHYPERTENSIVE THERAPY IN OUT-PATIENT CLINIC Abstract  similar documents
O. A. Plejko, A. O. Konradi
"... нормализации АД и количеству необходимых посещений врача, а также отличалась значительным экономическим ..."
 
Vol 9, No 1 (2013) CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina, O. Ju. Korennova, E. N. Loginova
"... Цель. Изучить клинико-экономическую эффективность обучения пациентов молодого возраста с ..."
 
Vol 1, No 2 (2005) INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA Abstract  similar documents
N. P. Kutishenko, N. A. Dmitrieva, Y. V. Lukina, M. P. Kozireva, Y. E. Semyonova, A. D. Deev, S. Y. Martsevich
"... weeks therapy. Criterion of treatment efficiency: increase in duration of trial with emburden/em ..."
 
Vol 3, No 2 (2007) THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS Abstract  similar documents
I. I. Sinitsina, V. A. Orlov, G. U. Zacharova, T. A. Gembitskaya
"... pectoris, molsidomine, tolerance for physical emburden/em Rational Pharmacother. Card. 2007; 2:20-25 ОПЫТ ..."
 
Vol 15, No 1 (2019) Carotid Atherosclerosis Severity in Unorganized Adult Population Abstract  similar documents
V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, S. A. Shalnova
 
Vol 11, No 1 (2015) PHARMACOEPIDEMIOLOGY AND THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT IN REAL-LIFE PRACTICE OF THE CARDIOLOGY REFERRAL CLINIC Abstract  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S. B. Fitilev
"... Arterial hypertension is a disease which leads to severe negative social and emeconomic/em consequences ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... efficacy but have emeconomic/em advantages. ..."
 
Vol 13, No 4 (2017) HEALTHCARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY IN POPULATION AGED 50-64 ACCORDING TO THE EPIDEMIOLOGICAL ESSE-RF STUDY Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, A. D. Deev, A. V. Kapustina, G. A. Muromtseva, S. E. Evstifeeva, S. A. Shalnova
"... of working people. Health deterioration and diseases emburden/em increment is one of apparent reasons ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
"... бисопролола. Фармакоэкономический анализ выявил, что для урежения ЧСС более выгодным с emэкономической/em точки ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... components according to multifactor origin of cardiovascular disease (emCVD/em). Correction of lipid metabolism ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... Currently, cardiovascular diseases (emCVD/em) remain the main problem in the world and in Russia ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... Цель. Изучить клиническую и emэкономическую/em целесообразность оценки риска развития сердечно ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... increases the budget load in 2.81 times. However, previous data demonstrate the emeconomic/em feasibility ..."
 
Vol 5, No 4 (2009) CLINICO-ECONOMICAL ANALYSIS OF THE TREATMENT EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES Abstract  similar documents
L. A. Haisheva, S. V. Shlyk, T. Y. Bykovskaya
"... Цель. Клинико-emэкономический/em анализ лечения артериальной гипертонии (АГ). Материал и методы. В ..."
 
Vol 4, No 3 (2008) EUROPEAN HEART HEALTH CHARTER Abstract  similar documents
статья Редакционная
"... . European Heart Journal. 2006;27(8):994-1005. 4. emEconomic/em emburden/em of cardiovascular diseases in the enlarged ..."
 
Vol 3, No 5 (2007) IDIOPATHIC SICK SINUS SYNDROME Abstract  similar documents
S. Y. Nikulina, V. A. Schulman, A. A. Chernova
"... Aim. To evaluate changes in hereditary emburden/em of sick sinus syndrome (SSS) in families of patients ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... of any medical technology is emeconomic/em value and cost-effectiveness. The objective of this review ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... region Russian citizens make up about ¼ of all deaths caused by cardiovascular diseases (emCVD/em) each year ..."
 
Vol 14, No 2 (2018) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov
"... Aim. To study the clinical and emeconomic/em advantages of patient-oriented treatment in comparison ..."
 
Vol 13, No 5 (2017) OFF-LABEL PRESCRIBING. POSSIBLE CAUSES, TYPES AND CONSEQUENCES. LEGAL REGULATION IN THE RUSSIAN FEDERATION Abstract  similar documents
S. Yu. Martsevich, A. R. Navasardjan, N. A. Komkova
"... of regulatory difficulties, emeconomic/em inexpediency and ethical considerations. An additional complication ..."
 
Vol 12, No 2 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 Abstract  PDF (Eng)  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... for cardiovascular disease (emCVD/em) grows. The nature of relationship between these indices in people without emCVD/em ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... into 2 groups based on their socio-emeconomic/em status: 77 patients received rivaroxaban and 49 - warfarin ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (emCVD/em) and its prevention (odds ratio ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... Aim. To study a pattern of concomitant cardiovascular diseases (emCVDs/em) and to estimate ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... indicate that during three years, in case of sacubitril/valsartan usage budgetary emburden/em can be reduced ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (emCVD/em). Material and methods ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... клиническую и социально-emэкономическую/em эффективность лечения артериальной гипертензии (АГ). Необходимо изучение ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"...   need  constant anticoagulation therapy. The high emeconomic/em efficiency of using coagulometers has  also ..."
 
Vol 13, No 4 (2017) PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) Abstract  similar documents
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
"... cardiovascular diseases (emCVD/em) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..."
 
Vol 6, No 5 (2010) THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION) Abstract  similar documents
Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina
"... систематическими ошибками при оценке эффектов лечения. Такие систематические ошибки наносят серьезный emущерб/em РКИ ..."
 
Vol 5, No 4 (2009) DOBUTAMINE STRESS-ECHOCARDIOGRAPHY: POSSIBILITY OF CLINICAL USAGE IN CARDIOLOGY PRACTICE Abstract  similar documents
M. A. Saidova
"... Currently stress-echocardiography or so-called emburden/em echocardiography is essential method ..."
 
Vol 3, No 5 (2007) ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME Abstract  similar documents
O. V. Reshetko, R. M. Magdeev, N. V. Furman
"... ., Luengo-Fernandez R., Gray A., et al. emEconomic/em emburden/em of car- diovascular diseases in the enlarged ..."
 
Vol 7, No 6 (2011) CURRENT APPROACHES TO EVALUATION OF THE MULTIVESSEL CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. N. Perutsky, I. B. Kovalenko, S. L. Konstantinov, T. I. Makeeva, M. V. Filatov
"... от ИБС — 50,1% [1]. Экономиче- ский emущерб/em от ССЗ в РФ в 2007 г. составил 2,8% внут- реннего валового ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... diseases (emCVD/em) in the Udmurt Republic (UR) of Russia. Material and methods. In prospective ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... затраты на апиксабан по сравнению с НМГ с переходом на варфарин оказались emэкономически/em высоко эффективными ..."
 
Vol 10, No 3 (2014) OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE Abstract  similar documents
E. L. Trisvetova
"... priority. Lancet 2008;371(9623):1480-2. 4. Oganov R.G., Kontsevaya A.V., Kalinina A.M. emEconomic/em emburden/em ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... diseases (emCVD/em) in the presence of limitations (chronic obstructive pulmonary disease – COPD ..."
 
Vol 15, No 2 (2019) Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital Abstract  similar documents
A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda
"... with cardiovascular diseases (emCVD/em) is an important clinical task. Aim. To study the detectability of subclinical ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... for a number of cardiovascular diseases (emCVD/em), is considered. The high prevalence of cardiovascular risk ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (emCVD/em) were among participants of the meeting. The importance of modern ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... of effective cardiovascular disease (emCVD/em) primary prevention. Such lesions include: arterial wall thickening ..."
 
Vol 12, No 6 (2016) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)." Part 1. Hospital Prospective Register of Patients after Acute Stroke (According to the Results of the Pilot Phase of the Study) Abstract  similar documents
S. A. Boytsov, S. Yu. Martsevich, N. P. Kutishenko, M. M. Loukianov, A. E. Mitichkin, R. V. Viskov, L. V. Stakhovskaya, N. A. Shamalov, G. P. Arutyunov, I. V. Kokareva, N. E. Parsadanyan, M. I. Chernyshova, A. V. Zagrebelnyy, N. A. Dmitrieva, A. V. Akimova, G. I. Nikitina, O. V. Lerman, V. P. Voronina, E. N. Belova, E. N. Kudryashov, A. D. Deev
"... of the closest outpatient clinics). Presence of cardiovascular diseases (emCVD/em) and their risk factors (RF ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... Кардиологии 2013;9(1) 5 Cardiovascular diseases (emCVD/em) are the most fre- quent cause of death in adults ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... -emэкономический/em метод: анализ «затраты-эффективность». Результаты. В группе В/А 75% пациентов достигли целевого АД ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... (emCVD/em) in patients with gout depending on the presence of MS. Material and methods. 56 patients (aged ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... , вместе с этим прогрес- сивно увеличиваются emэкономические/em затраты, связан- ные с этим заболеванием [9, 10 ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... продолжительность жизни и является emэкономически/em приемлемым для применения у пациентов с неклапанной ФП с точки ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (emCVD/em) are more effective ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... The role of gut microbiota in the pathogenesis of cardiovascular diseases (emCVD/em) and metabolic ..."
 
Vol 15, No 2 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cardiovascular diseases (emCVD/em). This allows it to be considered as a new marker of cardiovascular risk in women ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with the prevalence and mortality from cardiovascular diseases (emCVD/em). The presence of BAC on mammograms is associated ..."
 
Vol 3, No 1 (2007) EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova
"... to physical emburden/em, improved cardiac haemodynamics, parameters of POL and cell anti-oxidant protection ..."
 
Vol 2, No 4 (2006) CLINICAL EFFICACY OF MONOTHERAPY WITH INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION OF THE I-II DEGREES Abstract  similar documents
E. Yu. Тourkassova, T. G. Volkova, E. M. Idrissova, E. M. Vorobyeva, R. S. Karpov
"... in daily , day-time and nighttime BP , BP emburden/em and daytime BP variability were observed. Number ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... - velopment of the cardiovascular diseases (emCVD/em) reg- istry PROFIL with characteristics of 99 AF patients ..."
 
Vol 2, No 1 (2006) THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY Abstract  similar documents
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov
"... times decrease in BP emburden/em in daytime and nighttime were observed while BP emburden/em remained unchanged ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... emэкономически/em эффективного вмешательства, позволяющего снизить затраты на лечение по сравнению с рутинным ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... Aim. To evaluate cardiovascular diseases (emCVD/em) treatment in patients with type 2 diabetes mellitus ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... diseases (TRF for emCVD/em), subclinical structural and functional changes in the heart and vessels, as well ..."
 
Vol 14, No 5 (2018) Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” Abstract  similar documents
N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich
"... (AMI), to assess the influence of factors in medical history, especially cardiovascular diseases (emCVD/em ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... (emCVD/em), non-emCVD/em, all causes. A total of 10,650 deaths were registered: 8,726 in men (for 10 years) and 1 ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... Organization data cardiovascular diseases (emCVD/em) are the leading cause of death worldwide [1]. Among European ..."
 
Vol 6, No 4 (2010) THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) Abstract  similar documents
Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Getzsche, Thomas Lang, N. Chipigina
"... наносят серьезный emущерб/em РКИ, главным отличительным достоинством которых является именно устранение ..."
 
Vol 1, No 1 (2005) TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION Abstract  similar documents
O. V. Vikhireva, S. A. Shalnova, A. D. Deev
"... to quit smoking. To assess expected reduction of cardiovascular disease (emCVD/em) and total mortality relative ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... ) of cardiovascular disease (emCVD/em), duplex scanning of the common carotid arteries, transthoracic echocardiography ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... (emCVD/em) was significantly less (17) compared with non-vaccinated (38), р=0.03. The risk of infectious ..."
 
Vol 9, No 6 (2013) ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM Abstract  similar documents
M. A Kachkovsky, E. Yu. Ragozinа
"... ,3 до 55,9 [1]. Суммарный emэкономический/em emущерб/em от острого коронарного синдрома (ОКС) в РФ в 2009 г ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... metabolite as an independent risk factor for cardio- vascular diseases (emCVD/em) [3-5]. This promoted a few large ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... in patients of both groups was evaluated by emburden/em tests on treadmill, effective doses of bisoprolol ..."
 
Vol 5, No 4 (2009) EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE Abstract  similar documents
N. J. Borovkova, N. N. Borovkov, T. I. Maslov
"... also improved: average BP levels and hypertensive emburden/em time decreased, speed of morning BP raise ..."
 
Vol 14, No 1 (2018) RESPONSIBLE SELF-CARE – THE FUNDAMENTAL PRINCIPLES AND PLACE IN THE MODERN RUSSIAN HEALTHCARE SYSTEM Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, A. V. Kontsevaya, O. M. Drapkina
"... responsible self-care ... is essential to reduce the financial emburden/em on health systems". The term ..."
 
Vol 15, No 2 (2019) Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova, A. V. Starodubova, Т. М. Оstroumova, D. A. Bondarenko
"... and their important role in development of the overall disease emburden/em. In accordance with the clinical guidelines ..."
 
Vol 8, No 2 (2012) THE ANALYSIS OF FACTORS INFLUENCING THE TERMS OF HOSPITAL ADMISSION IN PATIENTS WITH ACUTE CORONARY SYNDROM (ACCORDING TO THE LIS STUDY DATA – LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION) Abstract  similar documents
M. L. Ginzburg, N. P. Kutishenko, S. Yu. Martsevich, A. V. Fokina, E. V. Daniels, A. V. Zaharova
"... Фармакотерапия в Кардиологии 2012;8(2) Cardio-vascular diseases (emCVD/em), namely ischemic heart disease (IHD) and ..."
 
Vol 9, No 3 (2013) IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION Abstract  similar documents
P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva
"... strong association with severity of coronary atheromatous emburden/em (left main coro- nary artery stenosis ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... . Socio-emeconomic/em emburden/em of atrial fibrillation in the Russ- ian Federation. Klinicheskaya Farmakologiya i ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... data, the type and duration of AF, cardiovascular diseases (emCVD/em), concomitant noncardiac pathology ..."
 
1 - 100 of 365 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)